Cargando…
The CD73 immune checkpoint promotes tumor cell metabolic fitness
CD73 is an ectonucleotidase overexpressed on tumor cells that suppresses anti-tumor immunity. Accordingly, several CD73 inhibitors are currently being evaluated in the clinic, including in large randomized clinical trials. Yet, the tumor cell-intrinsic impact of CD73 remain largely uncharacterized....
Autores principales: | Allard, David, Cousineau, Isabelle, Ma, Eric H, Allard, Bertrand, Bareche, Yacine, Fleury, Hubert, Stagg, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259490/ https://www.ncbi.nlm.nih.gov/pubmed/37261423 http://dx.doi.org/10.7554/eLife.84508 |
Ejemplares similares
-
CD73 Promotes Chronic Lymphocytic Leukemia
por: Allard, David, et al.
Publicado: (2022) -
On the mechanism of anti-CD39 immune checkpoint therapy
por: Allard, David, et al.
Publicado: (2020) -
CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
por: Allard, Bertrand, et al.
Publicado: (2012) -
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
por: Allard, Bertrand, et al.
Publicado: (2023) -
Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)